Objectives herpes simplex virus type 2 (hSV-2) is a prevalent infection with great variability in clinical and virological manifestations among individuals. this prospective cohort study aims to evaluate the natural history of hSV-2 reactivation in the genital area in the same group of women over time. Methods eighteen immunocompetent hSV-2 seropositive women were evaluated for viral shedding for 70 consecutive days within a median of 8 months (range 1-24 months) of hSV-2 acquisition and again approximately 2.5 years later from the original study. participants obtained daily swabs of genital secretions for hSV pCr and recorded genital symptoms. results the viral shedding rate was 29% during the initial study and 19% in the follow-up study (32% reduction, p=0.019). Subclinical shedding rate also decreased from 24% to 13% (37% reduction, p=0.032), as did the rate of days with genital lesions from 22% to 15% (33% reduction, p=0.24). the mean copy number during viral shedding remained unchanged over time at 4.8 log 10 c/mL (SD=2.0 and 1.6 during each study, respectively, p=0.33). Women with high viral shedding rates in the past were likely to continue to have high shedding rates (r=0.63, p=0.005). Conclusions Despite some reduction, high viral shedding rates persist in women with genital hSV-2 greater than 2 years after acquisition.
InTrOduCTIOn
Herpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcer disease 1 with more than 400 million people infected worldwide. HSV-2 infection is a major risk factor for both the acquisition and transmission of HIV-1. 2 The transmission of HSV-2 to partners usually occurs during episodes of asymptomatic shedding, with viral replication but no evidence of clinical disease. 3 Counselling of patients regarding transmission of HSV-2 is difficult because of high variability in viral shedding rates among individuals. To assess whether shedding rates change or remain stable in individual persons, we enrolled women who have participated in a prior shedding study 4 5 to obtain genital swabs approximately 2.5 years later.
MeThOds study participants and procedures
The study was conducted at the University of Washington (UW) Virology Research Clinic with HSV-2 seropositive women <2 years of acquisition of genital herpes infection. 4 5 Approximately 2.5 years later, these women returned to clinic to participate in a similar study. Only swabs from women not on antiviral therapy were used for analysis. UW Human Subjects Review Committee approved protocols and participants signed informed consent. After training, women obtained daily swabs of genital secretions of the cervicovaginal, vulvar and perianal area. 4 Participants obtained a separate swab of any genital lesions, maintained a dairy recording of genital lesions and were seen in clinic every 2 weeks.
Laboratory methods
HSV-1 and HSV-2 serostatus was established by the UW Western blot. 6 Vulvar and cervical swabs were evaluated by culture and PCR, while perianal swabs were evaluated by culture alone due to cost considerations. 5 Samples were evaluated for HSV DNA by PCR with specimens positive if results >150 copies of HSV DNA per mL of transport media (c/mL). Data from PCR were used for the reported analyses of vulvar and cervical swabs; findings using viral culture results are included in the supplement.
definitions and statistical analyses
Days with HSV detected by PCR (or isolated from culture) from any swab sample were considered days with viral shedding. Viral shedding rate was the number of days with positive PCR (or culture) divided by the number of days samples were collected. Subclinical shedding rate was calculated similarly but excluded days with genital lesions from both numerator and denominator. Recurrences were defined as the presence of any genital lesion consistent with HSV infection noted by the study participant or study clinician. The duration of a lesion was computed as the number of consecutive days with lesion. A Poisson regression in a linear mixed effects model with empirical variance estimation was done to estimate the change in shedding rate, the recurrence rate and genital lesions over time. Linear mixed models were used to assess changes in quantity of HSV DNA on positive swabs. Correlations between measures over time were also assessed using Spearman's correlation.
Clinical

resuLTs
Eighteen of 28 women (64%) who completed the initial study of viral shedding agreed to participate in this study. The median age was 26 (range 22-44). The demographic and clinical characteristics of the 18 women who participated in the follow-up study were not found to differ in age, race or baseline shedding rates from the 10 women who declined (data not shown).
All participants had symptoms consistent with primary genital herpes at the time of initial diagnosis. All women were HSV-2 seropositive and HIV and HSV-1 seronegative. The time since primary episode to the initial study was a median of 8 months (range 1-24 months), and the median time between the two sampling periods was 2.4 years (range 1.6-2.8 years).
In the follow-up study, the median number of days with swabs collected was 66 (range 45-82). The overall HSV shedding rate was 19% (range 0-71, table 1). Large variability was noted in the shedding rates detected by PCR among individual women with 10 women shedding on ≤10% of days, 3 on 10%-20% of days, 0 on 20%-30% of days and 5 on ≥30% of days. The subclinical shedding rate was 13% (range 0-66). Nine out of 18 subjects (50%) had at least 1 day of genital lesions. The mean per cent of days with genital lesions was 15% (range 0-59) with an annualised recurrence rate of 7.5. The mean duration of recurrences was 7.1 days.
Between the two study periods, the percentage of days on which HSV was detected decreased from 29% to 19%, a 32% decline (Risk Ratio=0.68, 95% CI 0.50 to 0.93, P=0.019). However, the women with high viral shedding rates in the past were likely to continue to have high shedding rates (r=0.63, P=0.005). The mean quantity of viral DNA detected remained unchanged at 4.8 log 10 c/mL ((SD)=2.0 and 1.6 during each study, respectively, P=0.33). An apparent decline in shedding rates was noted at all anatomic sites sampled.
The subclinical shedding rate decreased from 24% to 13%, a 37% reduction (RR=0.63, 95% CI 0.41 to 0.96, P=0.032). The mean amount of HSV DNA detected averaged 4.7 log 10 c/mL in the initial study and 4.4 log 10 c/mL in the follow-up study on days without lesions (SD=2.1 and 1.5 during each study, respectively, P=0.28).
The percentage of days with lesions demonstrated a trend towards reduction from 22% to 15%, a 33% decrease (RR=0.67, 95% CI 0.34 to 1.34, P=0.24). Recurrence duration was not found to differ, averaging 7.6 days and 7.1 days (P=0.74). Overall 64 recurrences were reported, 37 in the initial study and 27 in the follow-up study, of which 51 (80%) had a determined length. The remaining 13 recurrences were ongoing at the beginning or end of the observation period. There was a modest correlation in genital lesion rate over time (r s =0.39, P=0.10).
dIsCussIOn
To our knowledge, this study is the first to describe the natural history of viral shedding in the same group of persons at two time periods after acquisition of genital HSV-2 infection. Several measures of viral activity declined over the course of genital herpes, including overall shedding rate, subclinical shedding rate and lesions. However, many participants continued to have high rates of reactivation of genital HSV-2 almost 3 years after acquisition, with an average of about 1 out of 5 days with detectable virus in the genital tract.
We found that women with higher shedding rates in the initial study continued to have high shedding rates, supporting the idea of a virological 'set point', at which the virus-host interaction becomes established, similar to that observed in HIV. 7 Differences both in the immune response and in HSV-2 strains have been described, but whether host immunity or viral virulence determines the clinical course of HSV-2 infection is unclear.
Clinical
While a decline in HSV shedding rates appeared consistent among different anatomic sites, the vulvar and perianal areas remained a common site of HSV reactivation, while cervical shedding became less frequent in the follow-up study. Potential reasons for the differential decline in shedding rates may include differences in local immunity or differences in the ability of HSV to reactivate efficiently in various types of nerves. 8 The relative importance of shedding at each anatomic site with regard to infectiousness has not been determined, especially as condoms are likely to be more effective for cervical than for vulvar and perianal shedding.
In contrast to the frequency of shedding, the quantity of HSV, when detected, did not decrease with time. Mathematical modelling of genital HSV-2 has predicted that transmission of virus is more likely to occur at viral loads greater than 10 4 HSV DNA copies, 9 and the quantities of HSV observed in this study suggest that the risk of HSV-2 transmission to sexual partners and neonates remains even years after acquisition of this virus.
Strengths of this study include the enrolment of the same participants in the follow-up study to help elucidate the dynamics of intraperson reactivation of HSV-2 over time. There were a small number of participants, but they cooperated with daily sampling that is labour intensive but provides an accurate assessment of shedding rates. The only eligibility criterion for participation was symptomatic acquisition of genital HSV-2 within 2 years of study enrolment, without any severity requirement, thus potentially generalisable to HSV-2 seropositive persons. While not all participants in the first study subsequently enrolled in the follow-up study, their demographic and clinical characteristics were similar. It is possible that shedding observed at one site in the genital tract is a result from contamination from a different site, but widespread genital reactivation occurs in HSV-2 disease and is associated with a localised HSV-specific T cell infiltrate. 10 In summary, this study provides further evidence that genital HSV-2 infection is associated with high shedding rates, which decline somewhat with time in most persons. However, high shedding rates tend to persist for several years. Current recommendations for prevention of HSV transmission include disclosure to sex partners, consistent use of condoms and antiviral therapy. Persons with HSV-2 infection should be counselled that even without genital lesions and years after acquisition of infection, they continue to pose a potential risk of viral transmission to sexual partners.
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